Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (December 2020)
Kenneth J. Mandell, David Clark, David S. Chu, C. Stephen Foster, John Sheppard, and Todd C. Brady